With regard to cancer prevention, lipid-lowering agents such as statins (3-hydroxy-3-methyl-glutaryl-coenzyme A reductase and HMG-CoA reductase) have been shown to inhibit the formation and proliferation of metastatic cancer cells39,40. This evidence concerns the gene HMGCR and metastatic malignant neoplasm.